Skip to main content

Table 1 Clinicopathological characteristics of B-CH, B-LC and B-HCC patients

From: Effects of Let-7c on the processing of hepatitis B virus associated liver diseases

Groups

Observation index

P50 (P25, P75)

B-CH

n

90

Age

38.00 (33.00, 47.00)

Gender

  Female

23

  Male

67

AST (IU/L)

58.00 (32.25, 104.50)

ALT (IU/L)

93.50 (43.00, 177.75)

γGTP (IU/L)

39.00 (26.00, 64.50)

PLT (× 109/L)

178.00 (150.25, 210.25)

ALB (g/L)

4.20 (4.03, 4.48)

HBV-DNA

7.10 (4.20, 7.60)

B-LC

n

10

Age

53.50 (48.75, 54.75)

Gender

  Female

3

  Male

7

AST (IU/L)

69.00 (45.25, 82.00)

ALT (IU/L)

83.00 (40.75, 100.00)

γGTP (IU/L)

48.50 (39.00, 78.25)

PLT (× 109/L)

138.00 (87.00, 180.25)

ALB (g/L)

4.00 (3.28, 4.08)

HBV-DNA

6.20 (3.50, 7.30)

B-HCC

n

8

Age

50.00 (44.00, 65.00)

Gender

  Female

4

  Male

4

AST (IU/L)

33.50 (25.50, 42.75)

ALT (IU/L)

35.00 (21.75, 62.00)

γGTP (IU/L)

42.50 (22.00, 71.50)

PLT (× 109/L)

109.50 (86.50, 138.25)

ALB (g/L)

3.95 (3.80, 4.13)

HBV-DNA

N. D